80 FR 18 pgs. 4593-4594 - Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
Type: NOTICEVolume: 80Number: 18Pages: 4593 - 4594
Pages: 4593, 4594Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2015-01602 Filed 1-27-15; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
ACTION:
Notice of registration.
SUMMARY:
Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION:
[top] By notice dated September 25, 2014, and published in the Federal Register on October 7, 2014, 79 FR 60498, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742, applied to be registered as a manufacturer of a certain basic class of controlled substance. No comments or objections were submitted to this notice.
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of marihuana (7360), a basic class of controlled substance listed in schedule I.
In reference to drug code 7360, the company plans to manufacture a synthetic version cannabidiol in bulk for sale to its customers, who are final dosage form manufacturers. No other activity for this drug code is authorized for this registration.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01602 Filed 1-27-15; 8:45 am]
BILLING CODE P